FIDSX | RMBNX | FIDSX / RMBNX | |
Total Expense Ratio | 0.69 | 2.14 | 32% |
Annual Report Gross Expense Ratio | 0.69 | 2.14 | 32% |
Fund Existence | 44 years | 20 years | - |
Gain YTD | 8.611 | 0.419 | 2,056% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.09B | 217M | 501% |
Annual Yield % from dividends | 1.36 | 0.73 | 186% |
Returns for 1 year | 26.33 | 23.88 | 110% |
Returns for 3 years | 61.22 | 2.89 | 2,117% |
Returns for 5 years | 128.65 | 89.50 | 144% |
Returns for 10 years | 99.40 | 56.18 | 177% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LCMIX | 47.30 | 0.64 | +1.37% |
ClearBridge Mid Cap Growth IS | |||
CWSIX | 14.39 | 0.08 | +0.56% |
Carillon Chartwell Small Cap Value I | |||
MALOX | 20.82 | 0.07 | +0.34% |
BlackRock Global Allocation Instl | |||
RIVKX | 19.64 | -0.01 | -0.05% |
American Funds International Vntg R-4 | |||
ERHSX | 14.05 | -0.03 | -0.21% |
Eaton Vance Worldwide Health Sci R |